Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| Bhanji Muna (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 265 shares
@ $42.33, valued at
$11.2k
|
|
| 07/10/2023 |
4
| Bhanji Muna (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,867 shares
@ $39.3, valued at
$73.4k
|
|
| 07/06/2023 |
4
| Clark Eliana (EVP, Chief Technical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 360 shares
@ $40.51, valued at
$14.6k
|
|
| 06/16/2023 |
4
| CHASE WILLIAM J (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 1,673 shares
@ $0
Granted 2,447 options to buy
@ $45.2, valued at
$110.6k
|
|
| 06/16/2023 |
4
| Verwiel Frank (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/16/2023 |
4
| Keresty Georgia (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/16/2023 |
4
| GOODMAN JESSE (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/16/2023 |
4
| Crowley John F (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/16/2023 |
4
| Cohen Fred E (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/16/2023 |
4
| Bhanji Muna (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,508 shares
@ $37.21, valued at
$93.3k
Sold 1,641 shares
@ $38.22, valued at
$62.7k
Sold 689 shares
@ $39.1, valued at
$26.9k
|
|
| 01/06/2023 |
4
| LEONARD JOHN M (President and CEO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 6,673 shares
@ $37.21, valued at
$248.3k
|
|
| 01/06/2023 |
4
| Hicks Derek (EVP, Chief Business Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,812 shares
@ $37.21, valued at
$67.4k
|
|
| 01/06/2023 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,574 shares
@ $37.21, valued at
$95.8k
|
|
| 01/06/2023 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,427 shares
@ $37.21, valued at
$90.3k
|
|
| 01/06/2023 |
4
| Clark Eliana (EVP, Chief Technical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 105 shares
@ $51.74, valued at
$5.4k
Sold 231 shares
@ $34.48, valued at
$8k
Sold 1,692 shares
@ $37.21, valued at
$63k
|
|
| 01/06/2023 |
4
| BASTA JAMES (EVP, General Counsel) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,138 shares
@ $37.21, valued at
$42.3k
|
|
| 01/04/2023 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,500 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| LEONARD JOHN M (President and CEO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 7,848 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,187 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Goddard Glenn (EVP, CFO) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,062 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Keresty Georgia (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 5,197 shares
@ $0
Granted 7,688 options to buy
@ $38.49, valued at
$295.9k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Bhanji Muna (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 2,014 shares
@ $0
Granted 2,980 options to buy
@ $38.49, valued at
$114.7k
|
|
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Clark Eliana (EVP, Chief Technical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 10,527 shares
@ $0
Granted 15,395 options to buy
@ $79.85, valued at
$1.2M
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,148 shares
@ $112.25, valued at
$128.9k
Granted 13,816 shares
@ $0
Exercised 3,500 restricted stock units
@ $0
Granted 13,816 options to buy
@ $79.85, valued at
$1.1M
|
|
|
|
|